accountalert) n"May 26 (Reuters) - MAP Pharmaceuticals Inc has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for its experimental acute migraine drug. Allergan Inc had bought co-promotion rights to the drug Levadex in January...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-MAP Pharma files marketing application for migraine drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account